IPOs

Apimeds Pharmaceuticals US IPO Backs Bee Venom for Osteoarthritis Treatment
Xtalks
Sun, 05/18/25 - 10:35 pm
Apimeds
IPOs
osteoarthritis
Apitox
bee venom
‘Chaos’ in the biotech market has dampened hopes of a rebound. What does that mean for dealmaking and IPOs?
Pharma Voice
Tue, 04/15/25 - 09:54 am
biotech
biotech stocks
tariffs
M&A
IPOs
Market volatility compounds ‘already challenging’ year for biotech IPOs
Fierce Biotech
Fri, 04/11/25 - 11:21 am
biotech
IPOs
stock market
Donald Trump
tariffs
Backing from BioNTech powers ADC specialist DualityBio toward $200M Hong Kong IPO
Fierce Biotech
Mon, 04/7/25 - 11:33 am
Duality Biologics
IPOs
BioNTech
Biotech ‘megarounds’ hold steady as startups, VCs wait on IPOs
BioPharma Dive
Thu, 04/3/25 - 11:18 am
biotech
funding
IPOs
venture capital
Alopexx seeks $11M IPO to advance ex-Sanofi infectious disease drug
Fierce Biotech
Wed, 02/26/25 - 10:53 am
Alopexx
IPOs
Sanofi
Aardvark prices $94M IPO to fund Prader-Willi, obesity drug work
BioPharma Dive
Thu, 02/13/25 - 11:46 am
Aardvark Therapeutics
IPOs
Prader-Willi Syndrome
Vertex challenger Sionna prices $191M IPO
BioPharma Dive
Thu, 02/6/25 - 10:52 pm
Sionna Therapeutics
IPOs
cystic fibrosis
Sionna eyes up $156M IPO to fund cystic fibrosis trials
Fierce Biotech
Mon, 02/3/25 - 11:47 am
Sionna Therapeutics
IPOs
cystic fibrosis
[podcast]What to expect from the biotech IPO market in 2025
Fierce Biotech
Fri, 01/31/25 - 11:18 am
biotech
IPOs
JPMHC 2025
Metsera, Maze secure combined $415 million in IPOs
BioPharma Dive
Fri, 01/31/25 - 11:05 am
Metsera
Maze Therapeutics
IPOs
biotech
Beta Bionics targets $695 mln valuation in upsized US IPO
Medtech Dive
Tue, 01/28/25 - 10:42 am
Medtech
Beta Bionics
IPOs
insulin pumps
diabetes
Maze rolls out map to $131M IPO, as phase 2 kidney disease trial readies for dosing
Fierce Biotech
Tue, 01/28/25 - 10:41 am
Maze Therapeutics
IPOs
kidney disease
clinical trials
Metsera eyes $289M IPO to fund phase 3 weight loss trial
Fierce Biotech
Mon, 01/27/25 - 11:32 am
Metsera
obesity
IPOs
GLP-1 agonists
MET-097i
Vision loss biotech Aurion Biotech files for a $100 million IPO
Renaissance Capital
Mon, 01/27/25 - 11:29 am
Aurion Biotech
cell therapy
IPOs
vision loss
Ascentage raises $126m in first biotech IPO of 2025
Pharmaphorum
Mon, 01/27/25 - 11:15 am
Ascentage Pharma
IPOs
cancer
‘A really rational IPO environment’: What does it takes for a biotech to go public now?
Fierce Biotech
Fri, 01/24/25 - 11:44 am
biotech
IPOs
Septerna
Sofinnova
Rapport Therapeutics
Obesity biotech Aardvark eyes IPO as Ascentage makes $126M Nasdaq debut
Fierce Biotech
Fri, 01/24/25 - 11:21 am
IPOs
Aardvark Therapeutics
Ascentage Pharma
Here’s Why Beta Bionics Filing for an IPO Is a Big Deal
Medical Devices and Diagnostics Industry
Thu, 01/23/25 - 11:09 pm
Medtech
Beta Bionics
IPOs
iLet Bionic Pancreas
GSK, Merck and Pfizer in Ab&B’s sights as Chinese vaccine biotech files for IPO
Fierce Biotech
Thu, 01/23/25 - 11:40 am
Ab&B Bio-Tech
GSK
Merck
Pfizer
China
vaccines
IPOs

Pages